- Home
- GV vs VYNE Comparison
GV vs VYNE Comparison
Compare GV & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- VYNE
- Stock Information
- Founded
- GV 2013
- VYNE 2003
- Country
- GV Canada
- VYNE United States
- Employees
- GV N/A
- VYNE N/A
- Industry
- GV Other Consumer Services
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- VYNE Health Care
- Exchange
- GV Nasdaq
- VYNE Nasdaq
- Market Cap
- GV 6.8M
- VYNE 7.9M
- IPO Year
- GV 2022
- VYNE 2018
- Fundamental
- Price
- GV $1.81
- VYNE $0.41
- Analyst Decision
- GV
- VYNE Buy
- Analyst Count
- GV 0
- VYNE 2
- Target Price
- GV N/A
- VYNE $8.00
- AVG Volume (30 Days)
- GV 5.1M
- VYNE 3.1M
- Earning Date
- GV 10-21-2025
- VYNE 11-06-2025
- Dividend Yield
- GV N/A
- VYNE N/A
- EPS Growth
- GV N/A
- VYNE N/A
- EPS
- GV N/A
- VYNE N/A
- Revenue
- GV $7,773,905.00
- VYNE $476,000.00
- Revenue This Year
- GV N/A
- VYNE N/A
- Revenue Next Year
- GV N/A
- VYNE N/A
- P/E Ratio
- GV N/A
- VYNE N/A
- Revenue Growth
- GV N/A
- VYNE N/A
- 52 Week Low
- GV $1.00
- VYNE $0.28
- 52 Week High
- GV $9.60
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- GV 44.99
- VYNE 56.32
- Support Level
- GV $2.00
- VYNE $0.32
- Resistance Level
- GV $2.17
- VYNE $0.46
- Average True Range (ATR)
- GV 0.18
- VYNE 0.03
- MACD
- GV -0.05
- VYNE 0.02
- Stochastic Oscillator
- GV 2.67
- VYNE 71.15
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.